Up-regulating the heme oxygenase system with hemin improves insulin sensitivity and glucose metabolism in adult spontaneously hypertensive rats

Endocrinology

Volumn 151, Issue 2, 2010, Pages 549-560

  Ndisang, Joseph Fomusi ^a   Lane, Nina ^a   Syed, Noor ^a   Jadhav, Ashok ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

8 ISOPROSTANE; ADIPONECTIN; BILIRUBIN; CATALASE; CYCLIC AMP; CYCLIC GMP; FERRITIN; GLUCOSE; GLUCOSE TRANSPORTER 4; HEME; HEME OXYGENASE; HEME OXYGENASE 1; HEMIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; MESOPORPHYRIN; STRESS ACTIVATED PROTEIN KINASE; SUPEROXIDE DISMUTASE;

ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DISEASE EXACERBATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; ESSENTIAL HYPERTENSION; GASTROCNEMIUS MUSCLE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; GLYCEMIC CONTROL; HEART HYPERTROPHY; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN SYNTHESIS; KIDNEY DISEASE; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN SYNTHESIS INHIBITION; PROTEINURIA; RAT; SIGNAL TRANSDUCTION; SPONTANEOUSLY HYPERTENSIVE RAT; SPRAGUE DAWLEY RAT; TRANSCRIPTION REGULATION; UPREGULATION; WISTAR KYOTO RAT;

ADENYLATE KINASE; ADIPONECTIN; ANIMALS; BLOOD GLUCOSE; DNA PRIMERS; GLUCOSE INTOLERANCE; GLUCOSE TRANSPORTER TYPE 4; HEME OXYGENASE (DECYCLIZING); HEME OXYGENASE-1; HEMIN; INSULIN; INSULIN RESISTANCE; MUSCLE, SKELETAL; RATS; RATS, INBRED SHR; RATS, INBRED WKY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UP-REGULATION;

EID: 74949102157     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2009-0471     Document Type: Article

References (65)

1. Lima NK, Abbasi F, Lamendola C, Reaven G M 2009 Prevalence of insulin resistance and related risk factors for cardiovascular disease in patients with essential hypertension. Am J Hypertens 22:106-111
2. García-Puig J, Ruilope LM, Luque M, Fernández J, Ortega R, Dal-Ré R 2006 Glucose metabolism in patients with essential hypertension. Am J Med 119:318-326
3. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM,Savage PJ, Smith Jr SC, Spertus JA, Costa F 2005 Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112:2735-2752
4. Houstis N, Rosen ED, Lander ES 2006 Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 440: 944-948
5. Evans JL, Goldfine ID, Maddux BA, Grodsky GM 2002 Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocr Rev 23:599-622
6. Evans JL, Goldfine ID, Maddux BA, Grodsky GM 2003 Are oxidative stress-activated signaling pathways mediators of insulin resistance and β-cell dysfunction? Diabetes 52:1-8
7. Vinayagamoorthi R, Bobby Z, SridharMG 2008 Antioxidants preserve redox balance and inhibit c-Jun-N-terminal kinase pathway while improving insulin signaling in fat-fed rats: evidence for the role of oxidative stress on IRS-1 serine phosphorylation and insulin resistance. J Endocrinol 197:287-296
8. Paravicini TM, TouyzRM2008NADPHoxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities. Diabetes Care 31(Suppl 2):S170-S180
9. Bruce CR, Carey AL, Hawley JA, Febbraio MA 2003 Intramuscular heat shock protein 72 and heme oxygenase-1 mRNA are reduced in patients with type 2 diabetes: evidence that insulin resistance is associated with a disturbed antioxidant defense mechanism. Diabetes 52: 2338-2345
10. Sasaki T, Takahashi T, Maeshima K, Shimizu H, Toda Y, Morimatsu H, Takeuchi M, Yokoyama M, Akagi R, Morita K 2006 Hemearginate pretreatment attenuates pulmonary NF-κB and AP-1 activation induced by hemorrhagic shock via heme oxygenase-1 induction. Med Chem 2:271-274
11. Abraham NG, Kappas A 2008 Pharmacological and clinical aspects of heme oxygenase. Pharmacol Rev 60:79-127
12. Jadhav A, Torlakovic E, Ndisang JF 2008 Interaction among heme oxygenase, nuclear factor-κB, and transcription activating factors in cardiac hypertrophy in hypertension. Hypertension 52:910-917
13. Ndisang JF, Lane N, Jadhav A 2008 Crosstalk between the heme oxygenase system, aldosterone, and phospholipase C in hypertension. J Hypertens 26:1188-1199
14. Kaneto H, Nakatani Y, Kawamori D, Miyatsuka T, Matsuoka TA, Matsuhisa M, Yamasaki Y 2006 Role of oxidative stress, endoplasmic reticulum stress, and c-Jun N-terminal kinase in pancreatic β-cell dysfunction and insulin resistance. Int J Biochem Cell Biol 38:782-793
15. Bennett BL, Satoh Y, Lewis AJ 2003 JNK: a new therapeutic target for diabetes. Curr Opin Pharmacol 3:420-425
16. Baron AD, Clark MG 1997 Role of blood flow in the regulation of muscle glucose uptake. Annu Rev Nutr 17:487-499
17. Pryor WA, Squadrito GL 1995 The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am J Physiol 268:L699-L722
18. Li M, Kim DH, Tsenovoy PL, Peterson SJ, Rezzani R, Rodella LF, Aronow WS, Ikehara S, Abraham NG 2008 Treatment of obese diabetic mice with a heme oxygenase inducer reduces visceral and subcutaneous adiposity, increases adiponectin levels, and improves insulin sensitivity and glucose tolerance. Diabetes 57:1526-1535
19. Mosén H, Salehi A, Alm P, Henningsson R, Jimenez-Feltström J, Ostenson CG, Efendic S, Lundquist I 2005 Defective glucose-stimulated insulin release in the diabetic Goto-Kakizaki (GK) rat coincides with reduced activity of the islet carbon monoxide signaling pathway. Endocrinology 146:1553-1558
20. Potenza MA, Marasciulo FL, Chieppa DM, Brigiani GS, Formoso G, Quon MJ, Montagnani M 2005 Insulin resistance in spontaneously hypertensive rats is associated with endothelial dysfunction characterized by imbalance betweenNOand ET-1 production.AmJ Physiol Heart Circ Physiol 289:H813-H822
21. Aitman TJ, Glazier AM, Wallace CA, Cooper LD, Norsworthy PJ, Wahid FN, Al-Majali KM,Trembling PM, Mann CJ, Shoulders CC, Graf D, St Lezin E, Kurtz TW, Kren V, Pravenec M, Ibrahimi A, Abumrad NA, Stanton LW, Scott J 1999 Identification ofCd36(Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat Genet 21:76-83
22. Herlitz H, Lundin S, Henning M, Aurell M, Karlberg BE, Berglund G 1982 Hormonal pattern during development of hypertension in spontaneously hypertensive rats (SHR). Clin Exp Hypertens A 4:915-935
23. Ndisang JF, Jadhav A 2009 Up-regulating the hemeoxygenase system enhances insulin sensitivity and improves glucose metabolism in insulin-resistant diabetes in Goto-Kakizaki rats. Endocrinology 150:2627-2636
24. Jadhav A, Torlakovic E, Ndisang JF 2009 Hemin therapy attenuates kidney injury in deoxycorticosterone acetate-salt hypertensive rats. Am J Physiol Renal Physiol 296:F521-F534
25. Ndisang JF, Lane N, Jadhav A 2009 The heme oxygenase system abates hyperglycemia in Zucker diabetic fatty rats by potentiating insulin-sensitizing pathways. Endocrinology 150:2098-2108
26. Ndisang JF, Jadhav A 2009 Heme oxygenase system enhances insulin sensitivity and glucose metabolism in streptozotocin-induced diabetes. Am J Physiol Endocrinol Metab 296:E829-E841
27. Ndisang JF, Lane N, Jadhav A 2009 Upregulation of the heme oxygenase system ameliorates postprandial and fasting hyperglycemia in type 2 diabetes. Am J Physiol Endocrinol Metab 296: E1029-E1041
28. Lira VA, Soltow QA, Long JH, Betters JL, Sellman JE, Criswell DS 2007 Nitric oxide increasesGLUT4expression and regulatesAMPK signaling in skeletal muscle. Am J Physiol Endocrinol Metab 293: E1062-E1068
29. Bertagnolli M, Schenkel PC, Campos C, Mostarda CT, Casarini DE, Belló-Klein A, Irigoyen MC, Rigatto K 2008 Exercise training reduces sympathetic modulation on cardiovascular system and cardiac oxidative stress in spontaneously hypertensive rats. Am J Hypertens 21:1188-1193
30. Feld LG, Zamlauski-Tucker MJ, Springate JE, Van Liew JB 1995 Single nephron hemodynamics in spontaneously hypertensive rats. Proc Soc Exp Biol Med 209:185-189
31. Delanty N, Reilly MP, Pratico D, Lawson JA, McCarthy JF, Wood AE, Ohnishi ST, Fitzgerald DJ, FitzGerald GA 1997 8-Epi PGF2α generation during coronary reperfusion. A potential quantitative marker of oxidant stress in vivo. Circulation 95:2492-2499
32. Jeney V, Balla J, Yachie A, Varga Z, Vercellotti GM, Eaton JW, Balla G2002 Pro-oxidant and cytotoxic effects of circulating heme. Blood 100:879-887
33. Turkseven S, Kruger A, Mingone CJ, Kaminski P, Inaba M, Rodella LF, Ikehara S, Wolin MS, Abraham NG 2005 Antioxidant mechanism of heme oxygenase-1 involves an increase in superoxide dismutase and catalase in experimental diabetes. Am J Physiol Heart Circ Physiol 289:H701-H707
34. Levere RD, Martasek P, Escalante B, Schwartzman ML, Abraham NG 1990 Effect of heme arginate administration on blood pressure in spontaneously hypertensive rats. J Clin Invest 86:213-219
35. Saha S, Li Y, Anand-Srivastava MB 2008 Reduced levels of cyclic AMPcontribute to the enhanced oxidative stress in vascular smooth muscle cells from spontaneously hypertensive rats. Can J Physiol Pharmacol 86:190-198
36. Katsuki A, Suematsu M, Gabazza EC, Murashima S, Nakatani K, Togashi K, Yano Y, Adachi Y, Sumida Y 2006 Increased oxidative stress is associated with decreased circulating levels of adiponectin in Japanese metabolically obese, normal-weight men with normal glucose tolerance. Diabetes Res Clin Pract 73:310-314
37. Nakanishi S, Yamane K, Kamei N, Nojima H, Okubo M, Kohno N 2005 A protective effect of adiponectin against oxidative stress in Japanese Americans: the association between adiponectin or leptin and urinary isoprostane. Metabolism 54:194-199
38. Kubota N, Terauchi Y, Yamauchi T, Kubota T, Moroi M, Matsui J, Eto K, Yamashita T, Kamon J, Satoh H, Yano W, Froguel P, Nagai R, Kimura S, Kadowaki T, Noda T 2002 Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem 277:25863-25866
39. Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H, Hotta K, Nishida M, Takahashi M, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y 2000 Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-κB signaling through a cAMP-dependent pathway. Circulation 102:1296-1301
40. Mosén H, Salehi A, Henningsson R, Lundquist I 2006 Nitric oxide inhibits, and carbon monoxide activates, islet acid α-glucoside hydrolase activities in parallel with glucose-stimulated insulin secretion. J Endocrinol 190:681-693
41. Kamigaki M, Sakaue S, Tsujino I, Ohira H, Ikeda D, Itoh N, Ishimaru S, Ohtsuka Y, Nishimura M 2006 Oxidative stress provokes atherogenic changes in adipokine gene expression in 3T3-L1 adipocytes. Biochem Biophys Res Commun 339:624-632
42. Soares AF, Guichardant M, Cozzone D, Bernoud-Hubac N, Bouzaïdi-Tiali N, Lagarde M, Géloën A 2005 Effects of oxidative stress on adiponectin secretion and lactate production in 3T3-L1 adipocytes. Free Radic Biol Med 38:882-889
43. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB, Kadowaki T 2002 Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8:1288-1295
44. Holmes BF, Sparling DP, Olson AL, Winder WW, Dohm GL 2005 Regulation of muscle GLUT4 enhancer factor and myocyte enhancer factor 2 by AMP-activated protein kinase. Am J Physiol Endocrinol Metab 289:E1071-E1076
45. Chang L, Karin M 2001 Mammalian MAP kinase signalling cascades. Nature 410:37-40
46. Jin UH,Kang YJ, Chang YC, Kim CH2008 Secretion of atherogenic risk factor apolipoprotein B-100 is increased by a potential mechanism of JNK/PKC-mediated insulin resistance in liver cells. J Cell Biochem 103:908-919
47. Henningsson R, Alm P, Ekström P, Lundquist I 1999 Heme oxygenase and carbon monoxide: regulatory roles in islet hormone re-lease: a biochemical, immunohistochemical, and confocal microscopic study. Diabetes 48:66-76
48. Papadopoulos DP, Makris TK, Perrea D, Papazachou O, Daskalaki M, Sanidas E, Votteas V 2008 Adiponectin-insulin and resistin plasma levels in young healthy offspring of patients with essential hypertension. Blood Press 17:50-54
49. Vreman HJ, Ekstrand BC, Stevenson DK 1993 Selection of metalloporphyrin heme oxygenase inhibitors based on potency and photoreactivity. Pediatr Res 33:195-200
50. Zisman A, Peroni OD, Abel ED, Michael MD, Mauvais-Jarvis F, Lowell BB, Wojtaszewski JF, Hirshman MF, Virkamaki A, Goodyear LJ, Kahn CR, Kahn BB 2000 Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance. Nat Med 6:924-928
51. Wei Y, Sowers JR, Clark SE, Li W, Ferrario CM, Stump CS 2008 Angiotensin II-induced skeletal muscle insulin resistance mediated by NF-κB activation via NADPH oxidase. Am J Physiol Endocrinol Metab 294:E345-E351
52. Perticone F, Maio R, Sciacqua A, Andreozzi F, Iemma G, Perticone M, Zoccali C, Sesti G 2008 Endothelial dysfunction and C-reactive protein are risk factors for diabetes in essential hypertension. Diabetes 57:167-171
53. Peterson SJ, Drummond G, Kim DH, Li M, Kruger AL, Ikehara S, Abraham NG2008 L-4F treatment reduces adiposity, increases adiponectin levels, and improves insulin sensitivity in obese mice. J Lipid Res 49:1658-1669
54. Suliman ME, Yilmaz MI, Carrero JJ, Qureshi AR, Saglam M, Ipcioglu OM, Yenicesu M, Tong M, Heimbürger O, Barany P, Alvestrand A, Lindholm B, Stenvinkel P 2008 Novel links between the long pentraxin 3, endothelial dysfunction, and albuminuria in early and advanced chronic kidney disease. Clin J Am Soc Nephrol 3:976-985
55. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A 1989 Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 32:219-226
56. Pedrinelli R, Giampietro O, Carmassi F, Melillo E, Dell'Omo G, Catapano G, Matteucci E, Talarico L, Morale M, De Negri F, Di Bello V 1994 Microalbuminuria and endothelial dysfunction in essential hypertension. Lancet 344:14-18
57. Gschwend S, Pinto-Sietsma SJ, Buikema H, Pinto YM, van Gilst WH, Schulz A, de Zeeuw D, Kreutz R 2002 Impaired coronary endothelial function in a rat model of spontaneous albuminuria. Kidney Int 62:181-191
58. Sun MW, Zhong MF, Gu J, Qian FL, Gu JZ, Chen H 2008 Effects of different levels of exercise volume on endothelium-dependent vasodilation: roles of nitric oxide synthase and heme oxygenase. Hypertens Res 31:805-816
59. Potenza MA, Marasciulo FL, Tarquinio M, Quon MJ, Montagnani M 2006 Treatment of spontaneously hypertensive rats with rosiglitazone and/or enalapril restores balance between vasodilator and vasoconstrictor actions of insulin with simultaneous improvement in hypertension and insulin resistance. Diabetes 55:3594 - 3603
60. Sharma K, Ramachandrarao S, Qiu G, Usui HK, Zhu Y, Dunn SR, Ouedraogo R, Hough K, McCue P, Chan L, Falkner B, Goldstein BJ 2008 Adiponectin regulates albuminuria and podocyte function in mice. J Clin Invest 118:1645-1656
61. Lavrovsky Y, Schwartzman ML, Levere RD, Kappas A, Abraham NG 1994 Identification of binding sites for transcription factors NF-κB and AP-2 in the promoter region of the human heme oxygenase 1 gene. Proc Natl Acad Sci USA 91:5987-5991
62. Liu Y, Nakagawa Y, Wang Y, Liu L, Du H, Wang W, Ren X, Lutfy K, Friedman TC 2008 Reduction of hepatic glucocorticoid receptor and hexose-6-phosphate dehydrogenase expression ameliorates diet-induced obesity and insulin resistance in mice. J Mol Endocrinol 41:53-64
63. Jonas JC, Guiot Y, Rahier J, Henquin JC 2003 Haeme-oxygenase 1 expression in rat pancreatic βcells is stimulated by supraphysiological glucose concentrations and by cyclic AMP. Diabetologia 46: 1234-1244
64. Kapitulnik J, Maines MD 2009 Pleiotropic functions of biliverdin reductase: cellular signaling and generation of cytoprotective and cytotoxic bilirubin. Trends Pharmacol Sci 30:129-137
65. Pachori AS, Smith A, McDonald P, Zhang L, Dzau VJ, Melo LG 2007 Heme-oxygenase-1-induced protection against hypoxia/ reoxygenation is dependent on biliverdin reductase and its interaction with PI3K/Akt pathway. J Mol Cell Cardiol 43:580-592